Nigeria Confirms First Imported Bundibugyo Ebola Case as Outbreak Reaches West Africa

Nigeria's Federal Ministry of Health and Social Welfare confirmed on October 20, 2026, one imported case of Ebola Bundibugyo virus disease in the Federal Capital Territory, making Nigeria the fifth country to detect the virus in an outbreak declared in the Democratic Republic of the Congo on May 15, 2026. The patient is a woman who flew to Abuja from Uganda on October 3, according to the WHO Regional Office for Africa, and her symptoms began on October 7, four days after her arrival in Nigeria.

The WHO Regional Office for Africa reported on October 20 that the case was laboratory confirmed as Bundibugyo virus and that the patient was in isolation and receiving medical care. The agency said 44 contacts had been identified and were being monitored, and that infection prevention and control measures were being ramped up at the private health facility in Abuja where she sought care on October 11.

The detection takes the DRC-born outbreak into West Africa for the first time in the current response. Al Jazeera reported on October 21 that Nigerian officials said the case matches the Bundibugyo strain behind the DRC outbreak and that the Nigeria Centre for Disease Control and Prevention confirmed it after three molecular tests. WHO says Nigeria is the fifth country to detect the virus in this outbreak, which has also widened in East Africa, where Kenya has reported nine cases linked to an imported case in recent weeks.

Bundibugyo is a relatively rare Ebola virus species with no approved vaccine or specific treatment, although trials are under way. Ebola's incubation period is two to 21 days. Nigeria's last experience with the disease, in 2014, was different in important ways: the first case in Lagos was contained within three months, resulting in 20 infections and eight deaths, while the West African epidemic killed more than 11,000 people between late 2013 and 2016, according to Al Jazeera.

Key Facts

BBC News reported on October 21 that the patient is the Ugandan-born wife of a diplomat who is based in Abuja. She is 42 years old, spent two and a half weeks in Kampala and made a two-hour stopover in Addis Ababa, Ethiopia, on her return, according to Health Minister Muhammad Ali Pate. Pate told the BBC that she was stable and improving. The woman arrived home on October 3, and the case was confirmed on Tuesday, October 20, after three laboratory tests.

The Nigeria Centre for Disease Control and Prevention tested the woman for Ebola on October 19 after officials learned she had recently travelled to Uganda, and the positive result was confirmed the next day. Olajumoke Babatunde, director of the public health laboratory service at NCDC, said the agency did three levels of tests, all molecular, and that the strain was Bundibugyo. WHO also confirmed the strain. The patient first went to a private hospital thinking she had malaria, then to a second private hospital, and was admitted on October 11, according to BBC News. Public health authorities were alerted on October 19 after her condition failed to improve.

Authorities identified 44 contacts, most of them healthcare workers, including the patient's husband, a Swiss national living with her in Abuja. Pate said not all the contacts were in close proximity and that officials cast the net wide. Aviation Minister Festus Keyamo said 46 people, the 44 who came into contact with the woman at hospital and two who worked in her home, were banned from boarding flights. Nigeria stepped up Ebola surveillance at international airports with health screenings, temperature checks, movement tracking and digital health declarations, and neighbouring Cameroon tightened airport and port surveillance. No contacts are known to have developed symptoms.

The wider outbreak remains severe. Ebola Tracker reported on October 21 that the DRC bulletin for October 20 recorded 9,704 confirmed cases and 4,687 deaths, a case fatality rate of 48.3 percent. The bulletin counted 2,595 recovered patients and 1,041 people hospitalised in Ebola treatment centres. It recorded 67 new confirmed cases and 41 deaths, in line with a seven-day average of 70.3 cases a day. The outbreak remained in 66 health zones across eight provinces, with no new health zone since October 16. Of the 41 deaths, 23 occurred in the community outside treatment centres and 18 in treatment centres.

The response indicators show where the gaps are. Ebola Tracker reported on October 21 that 3,795 alerts were received, 3,582 were checked and 663 were retained as suspected cases, while 67 of 462 samples tested positive, or 14.5 percent. Only 79.7 percent of contacts were seen by follow-up teams, below the 85 percent threshold INSP set for itself. Treatment centres held 65 patients per 100 beds, with North Kivu over capacity at 488 patients for 410 beds. Vaccination has reached 8,762 people with the Ervebo vaccine since the campaign began on August 26, 2026, but North Kivu has run out of vaccine stock.

Analysis

The most important fact about Nigeria's case is not the single diagnosis but the delay before it was reached. Ayoade Alakija, a Nigerian physician who co-chairs a G7 committee for investment in global health, said it took 12 days from the woman falling sick for her to be tested for Ebola, potentially exposing many others. Al Jazeera reported on October 21 that authorities do not believe she was symptomatic during the flight, but the gap between the first hospital visit and the Ebola test is the kind of window that allows an outbreak to seed new chains.

What this really means is that Nigeria's detection system worked, but late, and late detection is a warning rather than a clean bill of health. The country activated its incident management system, identified 44 contacts and put 46 people on a no-fly list, which are strong initial steps. Yet the patient had already visited two private hospitals before public health authorities were alerted. Ebola readiness cannot stop at airports and public treatment centres. It has to include private clinicians who may see a malaria-like illness and not ask about travel.

The bigger picture here is that the DRC outbreak is no longer a single-country emergency. The virus has reached Uganda, Kenya and now Nigeria, and the DRC's own response indicators are under strain. Contact follow-up at 79.7 percent is below target, North Kivu is treating more patients than its beds can hold, vaccine stock has run out in the most affected province and safe burials are being postponed. Those failures are the conditions that let a virus travel across borders.

Why It Matters

This is the first time the current outbreak has reached West Africa, and Nigeria is the fifth country to detect the virus. The movement changes the risk map for the region. A case in Abuja, even an imported one, means health workers in a major West African city are now part of the response, and airports, hospitals and laboratories across a wider area need to be ready. The 44 contacts and the 46 people barred from flights are a reminder that contact tracing is not a bureaucratic exercise. It is the main tool for stopping a virus that spreads through close contact with bodily fluids.

The absence of an approved Bundibugyo vaccine or treatment raises the stakes. Trials are under way, but they are not the same as ready supply. The DRC's 48.3 percent case fatality rate shows how dangerous this species can be, and the outbreak's 9,704 confirmed cases and 4,687 deaths show how much capacity the response has already consumed. Every new country that detects a case adds demand for laboratory tests, personal protective equipment, trained contact tracers and treatment beds. It also adds pressure on the same limited vaccine stocks that are already exhausted in North Kivu.

At the same time, WHO's advice against travel and trade restrictions is a warning against panic. The agency wants countries to strengthen surveillance and testing, not to close borders. Nigeria's airport screening, Cameroon's tighter port and airport monitoring, and Kenya's nine cases all point to one lesson: the response has to be regional.

Next Up

The next 21 days are the critical window for Nigeria. The 44 contacts are being monitored for symptoms, and no contacts are known to have developed symptoms so far. Investigators are still trying to establish the likely source of infection and reconstruct the woman's full travel and exposure history. WHO and partners are supporting case investigation, contact tracing and infection prevention and control. The 46 people on the no-fly list will remain restricted as officials watch for any sign that the chain has widened.

Beyond Nigeria, the focus will stay on the DRC, where the outbreak remains in 66 health zones across eight provinces. The response needs to raise contact follow-up above the 85 percent threshold, restore vaccine supply in North Kivu and improve safe burial and laboratory access in Ituri and Tshopo. Kenya's nine cases since October 6 will also be watched for further spread. The test for the region is whether Nigeria's imported case becomes a single contained event or the start of a wider West African cluster. The answer will depend on how quickly the next suspected case is tested, isolated and traced.